CVS Stock Recent News
CVS LATEST HEADLINES
March investments totaled around $1,200, mainly in BDCs like Blue Owl Capital and Ares Capital, boosting annual dividend income by $100. Dividend income hit a new all-time record of $1,404, up 17% Y/Y driven by substantial purchases over the last twelve months. Focus remains firmly on maintaining rising BDC dividends and achieving a monthly increase of at least $100 in dividend income.
'Mad Money' host Jim Cramer talks the comeback of Dollar General and CVS shares in recent months.
'Mad Money' host Jim Cramer talks the comeback of Dollar General and CVS shares in recent months.
CNBC's Jim Cramer on Tuesday suggested why CVS and Dollar General have seen gains recently after lagging last year. He attributed the turnaround in part to the idea that these two have become the most competitive in their respective sectors.
CVS Health and UnitedHealth are two of the top companies leading the S&P 500 chart YTD. But which is the better investment now?
The medical sector stocks, notably the health insurance carriers, took a major drubbing in 2024 as Medicare Advantage (MA) plans continued to drive higher utilization costs, eating away at profits. These rising costs are illustrated by the medical benefits ratio (MBR), benefits expense ratio (BER), medical care ratio (MCR) or medical loss ratio (MLR), which is the percentage of premiums used to pay for medical services.
Major stock market indexes are down significantly this year, with many of the most valuable companies in the world leading the descent. However, some companies are performing well.
CVS Health Corporation surged 10% intraday and ended yesterday 6% higher, driven by a new CFO announcement and increased Medicare Advantage payments. Despite a challenging fiscal 2024, CVS is undervalued with strong growth potential, expecting 3.5% revenue growth and 6-11% EPS growth in 2025. CVS remains a solid investment due to its recession-resilient business model, low tariff impact, and trading below intrinsic value.
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
CVS Health (CVS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.